Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors

QR Code

Candidate prognostic markers in breast cancer: focus on extracellular proteases and their inhibitors

David M Roy,1 Logan A Walsh21Weill Cornell/Rockefeller/Sloan-Kettering Tri-Institutional MD-PhD Program, New York, NY, USA; 2Human Oncology and Pathogenesis Program, Memorial Sloan-Kettering Cancer Center, New York, NY, USAAbstract: The extracellular matrix (ECM) is the complex network of proteins...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Roy DM, Walsh LA
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2014
Sujets:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/4a2dce6037074d9e9b7cd232e3f81e4a
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

BAP1 methylation: a prognostic marker of uveal melanoma metastasis
par: Mathieu F. Bakhoum, et autres
Publié: (2021)

Knockout of immunotherapy prognostic marker genes eliminates the effect of the anti-PD-1 treatment
par: Naixue Yang, et autres
Publié: (2021)

Single nucleotide polymorphisms as susceptibility, prognostic, and therapeutic markers of nonsmall cell lung cancer
par: Zienolddiny S, et autres
Publié: (2011)

PI3K mutations in breast cancer: prognostic and therapeutic implications
par: Mukohara T
Publié: (2015)

Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups
par: Stephen Johnston, et autres
Publié: (2021)

HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now
par: Ilana Schlam, et autres
Publié: (2021)

Aromatase inhibitors in the treatment of breast cancer in post-menopausal female patients: an update
par: Schneider RE, et autres
Publié: (2011)

Heparanase: a potential marker of worse prognosis in estrogen receptor-positive breast cancer
par: Tamar Zahavi, et autres
Publié: (2021)

Correction: TERT promoter mutations and other prognostic factors in patients with advanced urothelial carcinoma treated with an immune checkpoint inhibitor
Publié: (2021)

Aromatase inhibitor-associated bone loss and its management with bisphosphonates in patients with breast cancer
par: Bauer M, et autres
Publié: (2012)

Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes
par: Jerusalem G, et autres
Publié: (2014)

Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication
par: Fangfang Liu, et autres
Publié: (2021)

Invasive breast cancer in Argentine women: association between risk and prognostic factors with antigens of a peptidic and carbohydrate nature
par: Croce MV, et autres
Publié: (2011)

Inherited predisposition to breast cancer in the Carolina Breast Cancer Study
par: Tom Walsh, et autres
Publié: (2021)

MCM3 upregulation confers endocrine resistance in breast cancer and is a predictive marker of diminished tamoxifen benefit
par: Sanne Løkkegaard, et autres
Publié: (2021)

Collagen fiber orientation disorder from H&E images is prognostic for early stage breast cancer: clinical trial validation
par: Haojia Li, et autres
Publié: (2021)

Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer
par: Lillian M. Smyth, et autres
Publié: (2021)

Accelerated partial breast irradiation with brachytherapy: patient selection and technique considerations
par: Trifiletti DM, et autres
Publié: (2015)

Towards personalized tumor markers
par: Vathany Kulasingam, et autres
Publié: (2017)

Predictive and prognostic transcriptomic biomarkers in soft tissue sarcomas
par: Eve Merry, et autres
Publié: (2021)

Targeting extracellular and juxtamembrane FGFR2 mutations in chemotherapy-refractory cholangiocarcinoma
par: Michael Bitzer, et autres
Publié: (2021)

Development of personalized treatments in lung cancer: focusing on the EGFR mutations and beyond
par: Suda K, et autres
Publié: (2013)

Mast Cells Resting-Related Prognostic Signature in Hepatocellular Carcinoma
par: Hao Zhang, et autres
Publié: (2021)

Ferroptosis-Associated Classifier and Indicator for Prognostic Prediction in Cutaneous Melanoma
par: Hao Zeng, et autres
Publié: (2021)

Na+/H+-Exchanger Family as Novel Prognostic Biomarkers in Colorectal Cancer
par: Xin Zhou, et autres
Publié: (2021)

Emerging role of tumor-derived extracellular vesicles in T cell suppression and dysfunction in the tumor microenvironment
par: Yuqi Wang, et autres
Publié: (2021)

Identification of genes involved in breast cancer and breast cancer stem cells
par: Apostolou P, et autres
Publié: (2015)

Cisplatin +/− rucaparib after preoperative chemotherapy in patients with triple-negative or BRCA mutated breast cancer
par: Maitri Kalra, et autres
Publié: (2021)

Recognizing Prognostic and Predictive Biomarkers in the Treatment of Non-Small Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors (ICIs)
par: Giustini N, et autres
Publié: (2021)

Dormancy in breast cancer
par: Banys M, et autres
Publié: (2012)

The Prognostic Value of Circulating Tumor DNA in Ovarian Cancer: A Meta-Analysis
par: Yuanyuan Lu MD, et autres
Publié: (2021)

The Prognostic Value of LncRNA SLNCR1 in Cancers: A Meta-Analysis
par: Lele Cong, et autres
Publié: (2021)

Prognosticating Outcome in Pancreatic Head Cancer With the use of a Machine Learning Algorithm
par: Zarrukh Baig MD, et autres
Publié: (2021)

Can population breast screening programs be leveraged to reduce the burden of breast cancer?
par: Nehmat Houssami
Publié: (2021)

Criteria-based curation of a therapy-focused compendium to support treatment recommendations in precision oncology
par: Frank P. Lin, et autres
Publié: (2021)

Dynamic contrast-enhanced breast MRI features correlate with invasive breast cancer angiogenesis
par: Jennifer Xiao, et autres
Publié: (2021)

The contribution of pathogenic variants in breast cancer susceptibility genes to familial breast cancer risk
par: Thomas P. Slavin, et autres
Publié: (2017)

Bones, breasts, and bisphosphonates: rationale for the use of zoledronic acid in advanced and early breast cancer
par: Allan Lipton
Publié: (2011)

Clinicopathological and Prognostic Significance of PRMT5 in Cancers: A System Review and Meta-Analysis
par: Zhenzhen Liang PhD, et autres
Publié: (2021)

Prognostic Value of a Pyroptosis-Related Long Noncoding RNA Signature Associated with Osteosarcoma Microenvironment
par: Xinxin Bu, et autres
Publié: (2021)